Contrat attribuéOpenSuppliesPoland

Sukcesywne dostawy produktów farmaceutycznych dla Szpitali Pomorskich Sp. z o.o. - produkty farmaceutyczne – programy lekowe 2026v62

6 fournisseurs attributaires•15 lots attribués•1,76 M € attribués

Acheteur: Szpitale Pomorskie Sp. z o.o. / Gdynia, Poland

Publié 13 juil. 2026Attribué 31 mai 2026

Pharmaceutical productsAntineoplastic and immunomodulating agents

Valeur attribuée

1,76 M €

Valeur estimée

1,76 M €

Attribué à 100% de la valeur estimée

Date d'attribution

31 mai 2026

Lauréats

Lots attribués

Valeurs d'attribution

Total de l'avis

1,76 M €

Somme des lots

1,96 M €

Le total de l'avis TED et les valeurs par lot ne correspondent pas exactement.

Lauréats

Asclepios S.A.

Wrocław, POL

2 lots

563 832 € Ce contrat

88 avis d’attribution•229 lots attribués•41,51 M € au total

BAXTER POLSKA Sp. z o.o.

Warszawa, POL

3 lots

495 501 € Ce contrat

23 avis d’attribution•40 lots attribués•13,40 M € au total

Abbvie Sp. z o.o.

Warszawa, POL

3 lots

468 767 € Ce contrat

14 avis d’attribution•21 lots attribués•14,76 M € au total

CENTRALA FARMACEUTYCZNA CEFARM SA

Warszawa, POL

2 lots

238 846 € Ce contrat

37 avis d’attribution•69 lots attribués•65,25 M € au total

Servier Polska Services Sp. z o.o.

Warszawa, POL

2 lots

111 917 € Ce contrat

22 avis d’attribution•28 lots attribués•4,00 M € au total

Janssen - Cilag Polska sp. z o.o.

Warszawa, POL

2 lots

49 290 € Ce contrat

26 avis d’attribution•49 lots attribués•32,20 M € au total

Lots attribués

Lot	Lauréat	Valeur	CPV principal
LOT-0033	Asclepios S.A.	335 678 €	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0039	Asclepios S.A.	228 154 €	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0040	BAXTER POLSKA Sp. z o.o.	200 447 €	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0041	Abbvie Sp. z o.o.	200 447 €	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0038	Abbvie Sp. z o.o.	155 893 €	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0035	BAXTER POLSKA Sp. z o.o.	147 867 €	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0036	BAXTER POLSKA Sp. z o.o.	147 187 €	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0043	CENTRALA FARMACEUTYCZNA CEFARM SA	143 392 €	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0037	Abbvie Sp. z o.o.	112 427 €	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0034	CENTRALA FARMACEUTYCZNA CEFARM SA	95 454 €	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0044	Servier Polska Services Sp. z o.o.	66 425 €	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0042	Servier Polska Services Sp. z o.o.	45 492 €	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0045	Non précisé	32 001 €	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0031	Janssen - Cilag Polska sp. z o.o.	24 797 €	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0032	Janssen - Cilag Polska sp. z o.o.	24 493 €	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)